medline.ch Gastroenterologie Pankreas Neoplasie

	Toward Timely Diagnosis of Pancreatic Cancer: Revolutionizing Early Detection Through Genomics, Artificial Intelligence, and Noninvasive Biomarkers. J Gastroenterol Hepatol Hussain MM, Qammar S, Wang JM, Zhai AQ, Li FY, Hu HJ. PMID: 41692706 [PubMed - as supplied by publisher]
	Three-Year Long-Term Outcomes in Patients With Unresectable Hepatocellular Carcinoma Treated With Atezolizumab Plus Bevacizumab Treatment in Clinical Practice. Cancer Med Ohama H, Hiraoka A, Tada T, Hirooka M, Kariyama K, Tani J, Atsukawa M, Takaguchi K, Itobayashi E, Fukunishi S, Tsuji K, Ishikawa T, Tajiri K, Tanaka H, Toyoda H, Ogawa C, Nishimura T, Hatanaka T, Kakizaki S, Kawata K, Naganuma A, Kosaka H, Matono T, Kuroda H, Yata Y, Nishikawa H, Imai M, Aoki T, Ochi H, Tamai H, Komatsu S, Tada F, Nakamura S, Nakamura Y, Miyake T, Yoshida O, Nouso K, Morishita A, Itokawa N, Okubo T, Arai T, Tsutsui A, Nagano T, Tanaka K, Matsuura T, Koshiyama Y, Kanayama Y, Noritake H, Enomoto H, Matsui K, Kaibori M, Fukumoto T, Hiasa Y, Kudo M, Kumada T, RELPEC Group and HCC 48 Group. PMID: 41692425 [PubMed - indexed for MEDLINE]
	Discovering Hereditary Risk Through Surveillance: A Prospective Genetic Analysis of Individuals With Familial Pancreatic Cancer. United European Gastroenterol J Paiella S, Secchettin E, Archibugi L, De Luca R, Bonifacio C, Laghi L, Lionetto G, Milanetto AC, Sereni G, Coluccio C, Lauri G, Dal Buono A, Patruno M, Gabriel G, Sassatelli R, Binda C, Bonvissuto D, Uliana V, Malleo G, Cavestro GM, Terrin M, Martino S, Pasquali C, De Pastena M, De Cobelli F, Poletti V, Venturini E, Puzzono M, Zerbi A, Arcidiacono PG, Salvia R, Falconi M, Capurso G, Carrara S. PMID: 41691430 [PubMed - indexed for MEDLINE]
	Pleiotropic mechanisms of cancer-associated fibroblast-mediated resistance in hepatocellular carcinoma: emerging therapeutic vulnerabilities and targeting strategies. Cancer Gene Ther Xie W, Fang J, Wang Z, Li X, Du J, Ling C. PMID: 41691133 [PubMed - as supplied by publisher]
	A digital quality measure for emergency presentation of pancreatic cancer. Br J Cancer Khalaf N, Sandoval G, Zimolzak AJ, Kapadia P, Liu Y, Singh H. PMID: 41691061 [PubMed - as supplied by publisher]
	Consensus-based validation of key quality indicators in pancreatic cancer surgery in Catalonia: A modified Delphi study. Cir Esp (Engl Ed) Guarga L, Sánchez-Velázquez P, Badia JM, Ballesteros M, Esteban L, Busquets J, Espín-Álvarez F, Sánchez-Cabus S, Ausania F, Pando E, Jorba RM, García-Domingo M, Lopez-Ben S, Escartín A, Burdio F, García-Borobia F, Borràs JM, Manchon-Walsh P. PMID: 41690615 [PubMed - as supplied by publisher]
	Microbial medicines: Unlocking the therapeutic potential of the microbiome in cancer treatment. J Control Release Canowitz A, Kamble NS, Muck N, Kaur K, Garay N, Bellala P, Gabani BB, Kotagiri N. PMID: 41690480 [PubMed - as supplied by publisher]
	Insulin resistance: The central node of convergence between unfolded protein response, diabetes, and cancer. Mol Aspects Med Abdullah KM, Sharma G, Anjum B, Alam MF, Yadav S, Singh Y, Sinha RA, Venkatesh V, Siddiqui JA, Chakravarti B. PMID: 41690012 [PubMed - as supplied by publisher]
	Lactate metabolism-related interaction perturbation network enables robust stratification of hepatocellular carcinoma. Discov Oncol Li S, Wang L, Xing X, Li X. PMID: 41689750 [PubMed - as supplied by publisher]
	Dietary intake of antioxidant vitamins and risk of pancreatic cancer: the Japan public health center-based prospective study. Eur J Nutr Uesugi S, Kito K, Yamaji T, Iwasaki M, Inoue M, Tsugane S, Sawada N. PMID: 41689639 [PubMed - in process]
	ASO Visual Abstract: Oncological Adequacy of R1 Vascular Margin in Minimally Invasive Liver Surgery for Hepatocellular Carcinoma and Colorectal Liver Metastases: A Meta-analysis. Ann Surg Oncol Procopio F, Memeo R, Del Fabbro D, Abdelhadi S, Reissfelder C, Edwin B, Milana F, Troisi RI, Torzilli G, Minimally Invasive R1 Vascular Group. PMID: 41688832 [PubMed - as supplied by publisher]
	PanMETAI - a high performance tabular foundation model for accurate pancreatic cancer diagnosis via NMR metabolomics. Nat Commun Wu DN, Jen J, Fajiculay E, Hsu MF, Chang MC, Yeh JC, Sargsyan K, Kupcinskas J, Skieceviciene J, Steponaitiene R, Morkunas E, Gedgaudiene G, Hsu CP, Chang YT, Hu CM. PMID: 41688460 [PubMed - indexed for MEDLINE]
	Neoadjuvant chemotherapy enables fertility preservation without compromising oncologic outcomes in early cervical cancer â‰¥2Â cm: A systematic review and meta-analysis. Eur J Surg Oncol Vincze Á, Márai D, Frivaldszky L, Rancz A, Hegyi P, Ács N, Bánhidy F, Keszthelyi M, Szentes BL, Sipos Z, Lintner B. PMID: 41687593 [PubMed - as supplied by publisher]
	NALIRIFOX versus nab-paclitaxel and gemcitabine in older patients with treatment-naive metastatic pancreatic cancer: a subgroup analysis of the pivotal NAPOLI 3 trial. ESMO Open Macarulla T, Cid RP, Womack MS, Gracian AC, Zervoudakis A, Hatoum H, Chung V, Patel A, Paulson AS, Pant S, O'Reilly EM, Hubner RA, Van Cutsem E, Bekaii-Saab T, Zhang L, Li J, Chen H, Maxwell F, Wainberg ZA, Melisi D. PMID: 41687160 [PubMed - as supplied by publisher]
	A Phase 2 Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2. Clin Cancer Res Huffman BM, Diossy M, Yurgelun MB, Horick N, Li YY, Crowdis J, Nguyen H, Parmar K, Kochupurakkal BS, Vonk L, Lam H, Ramsey K, Andrews E, Loeb SC, Culnane L, Biller LH, Bullock AJ, Enzinger A, Giannakis M, Jackson NA, Ng K, Nowak JA, Patel AK, Perez KJ, Rattani A, Rubinson DA, Schlechter BL, Singh H, Cai M, Raghavan S, Clark JW, Peters ML, Weipert CM, Wolpin BM, D'Andrea AD, Shapiro GI, Aguirre AJ, Szallasi Z, Cleary JM. PMID: 41686836 [PubMed - as supplied by publisher]
	Pancreatic Cystic Neoplasm Risk Among Individuals With Diabetes. JAMA Netw Open Cho IR, Chang SH, Lee SH, Han KD, Chung KH, Lee MW, Choi JH, Paik WH, Ryu JK. PMID: 41686439 [PubMed - indexed for MEDLINE]
	Development of an artificial intelligence-based prediction platform for early recurrence of resectable pancreatic cancer after curative surgery-toward future use as an indication for neoadjuvant treatment: a retrospective multicenter cohort study. Ann Surg Treat Res Yoon SJ, Kim SH, Kim H, Shin SH, Heo JS, Hong SS, Kang CM, Kim KS, Hwang HK, Han IW. PMID: 41684632 [PubMed]
	Metabolic Reprogramming and Ferroptosis: Unlocking New Therapeutic Frontiers in Cancer and Diabetes. Antioxid Redox Signal Huo Y, Xia Y, Zhang Q, Li Y, Zhao Y, Li Z, Zhu D, Ma F, Gu Z, Zhang N, Gao Y. PMID: 41684242 [PubMed - as supplied by publisher]
	Clinical Significance of Cytokeratin 19-Fragments (CYFRA 21-1), Osteopontin (OPN) and Human Epididymis Protein 4 (HE4) in Pancreatic Adenocarcinoma. Int J Mol Sci Dima AC, Balaban DV, Stanescu-Spinu II, Teodorescu A, Manucu G, Coman LI, Dima A, Betianu C, Tanase M, Miricescu D, Jinga M, Carstoiu C. PMID: 41683979 [PubMed - indexed for MEDLINE]
	Exploring the Role of Extracellular Vesicles in Pancreatic and Hepatobiliary Cancers: Advances Through Artificial Intelligence. Int J Mol Sci Trifylli EM, Angelakis A, Fortis SP, Kriebardis AG, Papadopoulos N, Koustas E, Sarantis P, Karamouzis MV, Manolakopoulos S, Deutsch M. PMID: 41683945 [PubMed - indexed for MEDLINE]

Artikel 1 - 20 / 59086

Seite 1 von 2955

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung